Literature DB >> 18561582

American Acne & Rosacea Society rosacea medical management guidelines.

James Q Del Rosso1, Hilary Baldwin, Guy Webster.   

Abstract

OBJECTIVES: The objectives of these Guidelines are to provide an overview of the fundamental disease state of rosacea and quality of life implications and outline available pharmacological treatments for rosacea with reference to supporting research and literature. The pharmacological agents discussed are inclusive of those that are FDA-approved based on phase 3 pivotal trials, commonly used agents based on extensive clinical experience, and less commonly used alternatives reported in peer-reviewed literature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18561582

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  5 in total

1.  Oxymetazoline (topical): rosacea.

Authors:  Joyce A Generali; Dennis J Cada
Journal:  Hosp Pharm       Date:  2013-07

2.  Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).

Authors:  James Q Del Rosso; Emil Tanghetti; Guy Webster; Linda Stein Gold; Diane Thiboutot; Richard L Gallo
Journal:  J Clin Aesthet Dermatol       Date:  2020-06-01

3.  Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

4.  Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses: Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected Skin Care as an Effective Therapeutic Approach.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2011-08

5.  Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel.

Authors:  Alvin B Coda; Tissa Hata; Jeremiah Miller; David Audish; Paul Kotol; Aimee Two; Faiza Shafiq; Kenshi Yamasaki; Julie C Harper; James Q Del Rosso; Richard L Gallo
Journal:  J Am Acad Dermatol       Date:  2013-07-18       Impact factor: 11.527

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.